Antibody Production Market Market | Industry Analysis 2018-2025Posted by Sandeep Salunkhe on April 12th, 2019 Increase in adoption of targeted immunotherapy, improved approval rate of therapeutic antibodies by regulatory authorities, and rise in R&D expenditure of pharmaceutical and biotechnology companies drive the growth of the global antibody production market. In addition, increase in incidence of infectious diseases and growth in demand for protein therapeutics fuel the market growth. However, high cost of primary antibodies restrains the market growth. Increase in R&D activities for the development of advanced antibodies and the growth in adoption of targeted immunotherapy are expected to provide opportunities for the market. The global antibody production market is segmented by process, end user, and region. Based on process, the market is categorized into upstream processing, downstream processing, and filtration. The upstream processing segment is further divided into bioreactors and consumables. Download Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3573 The bioreactors segment is subdivided into large-scale bioreactors and single-use bioreactors, whereas consumables segment is subsegmented into media and buffers & reagents. The market by filtration is classified into filtration systems and filtration consumables & accessories. By end user, the market is classified into pharmaceutical & biotechnology companies, diagnostic laboratories, and research institutes. Geographically, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. The companies profiled in the report are GeneTex, Inc., Thermo Fisher Scientific, Inc., Eli Lilly and Company, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, Abcam PLC, and FiberCell Systems Inc. Key Benefits
Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3573 Like it? Share it!More by this author |